Drug Interactions in Iranian Veterans With Chronic Spinal Cord Injury - A Descriptive Study by Divanbeigi , Ashkan et al.
Introduction  
Approximately 2000 people are living in Iran with spinal 
cord injuries related to the war. The average life expectancy 
of people with spinal cord injury is approximately 90% of 
normal individuals one year after the injury.1,2 A spinal 
cord injury that lasts more than a year is called a chronic 
spinal cord injury, which can cause various physical 
and mental conditions in the long term. The Veterans 
Spinal Cord Injury Center has widely implemented the 
screening program for injured veterans in the health field. 
In this program, veterans are periodically visited at home 
and examined each year in specialized medical centers.3,4 
Patients with spinal cord injury take more medication 
because of chronic and comorbid problems. During 
these visits, it felt that the number of drugs used by these 
patients was much higher than the normal form. This was 
a sensitive issue and should investigate.  
Whenever the use of a second drug alters the specific 
effect of a drug prescribed for a patient, drug interference 
occurs. A variety of drug interactions causes many of the 
side effects of the drug. It can found in various forms, such 
as drug interactions with drugs, drugs with foods, drugs 
with environmental factors, and drugs with diseases.5,6 
Many physicians and pharmacists do not spend the time 
needed to monitor all prescription and over-the-counter 
medications closely, and this inaccuracy in prescribing 
medications, especially for patients on a multi-drug 
regimen, can lead to drug interactions.7,8 Patients with 
chronic refractory diseases require multiple medications 
because of the long course of the disease that usually leads 
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to the addition of other diseases to the primary problem. 
The advent of drug interactions in these patients can affect 
the extent and duration of the effect of the drug, meaning 
that none of the drugs has the full expected effects.9,10 
Drug interactions can also lead to a new disease, impaired 
drug tolerance, and deprivation syndrome, leading to 
physician misstatement in the diagnosis of the disease. It 
is more likely to be intolerant to drugs that have many 
drug interactions with other medications that mistakenly 
prescribed, and sometimes these interactions may lead 
to a new disease in the patient that may lead to more 
medications administered to the patient. In addition to 
damaging different organs, this issue increases the cost of 
the patient and their supportive treatment system.11,12
This study aimed to investigate possible drug 
interactions in veterans with chronic spinal cord injury 
referred to Tehran Khatam Alanbia hospital during the 
2015 screening program. 
Materials and Methods
This descriptive study of the cross-sectional studies 
was carried out retrospectively in 2015 under the Shefa 
Neuroscience Research Center’s supervision, examining 
the medical records of veterans with spinal cord injury 
participating in the health screening program at Khatam 
Alanbiya hospital in Tehran. Integration criteria At least 
one year has passed since the spine injury, there is no 
date of hospitalization and mechanical ventilation three 
months before entering the center. Demographic data, 
comorbidities, used drugs, and the level of involvement 
collected. The types of injuries were determined based on 
the severity of the injuries caused by full or partial injuries 
and injuries to the neck, thoracic and lumbosacral, 
quadriplegia, and paraplegia. The number, type, and 
amount of all medications were collected by studying case 
files and questionnaires. According to the Food and Drug 
Administration (FDA), drug interactions among the 
drugs used for each patient has evaluated and classified 
into three severe, moderate, and weak groups. In severe 
interactions, simultaneous administration of two drugs 
is prohibited, in moderate interference, with caution, and 
in poor interference, the patient should inform of any 
potential complications.13
The data has recorded in each patient’s file. Demographic 
data, medications, drug interactions, drug, and severity of 
drug interactions were analyzed by SPSS software version 
21. Data were reported as percent, mean and standard 
deviation.
Results
The study population consisted of 404 men, ranging in 
age from 41 to 74, with a mean of 51.6 ± 6.4 years. The 
average post-SCI period was 29.09 ± 5.07 years. Thirty-
four veterans (8.4%) had quadriplegia, and 370 (91.6%) 
were paraplegic. One hundred forty-two of them (35.1%) 
had a complete injury, and 262 veterans (64.8%) had 
incomplete injuries. Comorbidities have listed in Table 1.
The number of drugs used was 3 to 28, with 5.3 ± 10.1 
types of drugs per day.
In the study population, antidepressants used more 
than other drugs. Three hundred seventy-one people 
were taking antidepressants. Antacid drugs 88.6%, 
Anticonvulsants 79.2%, Antihyperlipidemic agents 68.3%, 
and Antihypertensive agents 65.6%, Vitamin and mineral 
combinations 65.1%, and other drugs were next (Table 2). 
Only 17 veterans (4.2%) had no drug interactions. The 
number of drug interactions varied from 1 to 38, with an 
average of 5.9 ± 12.8 interactions per patient. The total 
number of interactions was 2856, of which 32.5% were 
weak, 55.3% moderate, and 12.2% severe, with a 95% 
confidence interval.
Among the severe drug interactions in the study, the 
highest number belonged to the antidepressant drug 
group. Among the 349 severe interactions, there was 
at least one antidepressant drug in 230 cases, of which 
126 were interactions between the two antidepressants, 
the most common antidepressant drug being the two 
SSRIs (selective serotonin reuptake inhibitor) and TCAs 
(tricyclic antidepressant) with 92 interferences.
The most common severe interactions were fluvoxamine 
and nortriptyline. Valproic acid and Clonazepam in 
the moderate group, Ranitidine, and Acetaminophen 
codeine, had the mildest group interactions.
Discussion
According to the results of this study, almost all veterans 
with spinal cord injury had drug interaction. This 
finding is important because these interactions can not 
only lead to prolonged illness and failure to respond 
appropriately to treatment, but may also cause the patient 
to discontinue one or more medications, or may need to 
add medications. Since patients’ health is the top priority 
of the health care system; therefore, drug interactions and 
their complications should avoid for faster improvement. 
Drug interactions are also economically important in 
Table 1. Comorbidities of Veterans With Chronic Spinal Cord Injury
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and here the issue of the physician’s attention to other 
medicines used by the patient becomes apparent.12 
Our study showed that about 12% of all drug 
interactions in patients are of severe interactions. In this 
regard, other studies’ results were varied and more or less 
than the results obtained in this study. Some studies of 
patients with chronic diseases have reported very few 
drug interactions.20-23 A study of antidepressant drug 
interactions with antihypertensive and hypoglycemic 
drugs found that of the 663 patients under study, only 
29 patients had drug interactions.24 While some other 
studies show that patients with chronic diseases are 
more susceptible to multiple drug interactions, for 
example, a study of US war casualties found that the 
effect of specific drug components has led to specific 
biological changes in about 90% of people receiving 
the drug. In that study, the highest number of drug 
interactions related to antidepressants25 is similar to 
the present study results. Our study also showed that 
among antidepressants, most interactions were between 
tricyclic antidepressants and selective serotonin reuptake 
inhibitors. In other studies, antidepressants identify as the 
most common drugs with interactions. In one study of 
more than 1000 US war casualties, 62% of patients under 
the age of 60 and 96% of patients over the age of 60 were 
taking specific antidepressant medications, the majority 
of those who observed drug interactions consumed 5 to 
6 drugs, including antidepressants.25-27 Another study 
in Australia found that 15% of combat casualties use 
at least one antidepressant, and only 8% of them have 
drug interactions.28 While our study showed that 91% of 
patients took antidepressants, and most of them had drug 
interactions.  
Many of the drugs used to treat veterans with chronic 
illnesses are specific components of the drug, given their 
diseases that are not commonly seen in other social 
groups. Some of the specific drug components in these 
patients can lead to specific biological changes that judge 
the extent of the interference more complicated. In the case 
of antidepressants with the most interactions, it may seem 
that the problem may solve by prescribing single-family 
drugs rather than multiple families. While single-family 
drugs classified according to one of the pharmacological 
aspects of the drug, other directions may differ.26-29
Conclusion
The results of this study highlight the necessity of 
developing a strategy for investigating and preventing 
drug interactions in war injuries. Also, to reduce the side 
effects of drug interactions at the time of administration 
of the new drug, it is necessary to consider the biological 
differences in these patients due to taking several drugs.
The list of drug interactions is pervasive, with some 
added over time. Therefore, it is advisable to use the 
available scientific resources in groups at higher risk for 
Table 2. Type of Drugs Used by Veterans With Chronic Spinal Cord Injury




Antihyperlipidemic agents 276 68.3
Antihypertensive agents 265 65.6
Vitamin and mineral combinations 263 65.1
Miscellaneous GI agents 250 61.9
Cardiovascular agents 220 54.5
Antiplatelet agents 210 52.0
Uterotonic agents 199 49.3
Laxatives 190 47.0
Antiasthmatic combinations 187 46.3
Anxiolytics, sedatives, and hypnotics 178 44.1
Muscle relaxants 167 41.3
Antidiabetic agents 142 35.1
Analgesics 111 27.5
Anticoagulants 95 23.5
Dermatological agents 81 20.0
Antigout agents 74 18.3
Antipsychotics 59 14.6
Herbal products 40 9.9
Ophthalmic agents 34 8.4
Glucocorticoids 32 7.9
Antiarrhythmic agents 25 6.2
Antibiotics 23 5.7
Bone resorption inhibitors 23 5.7
Antiemetic agents 10 2.5
CNS stimulants 7 1.7
addition to the risks to patients’ health and may increase 
the frequency of patient referrals and unnecessary 
paraclinical testing and thus increase medical costs.
The high cost of using overlapping drugs comprises a 
high percentage of the healthcare support budget of these 
patients, which may lead to a reduction in the number of 
services needed in this group.14,15
The results confirm the findings of a study conducted 
on 150 wounded in Tehran, showing that 148 patients 
had interfered with their medication.16 According to the 
results of this study, the more drugs the patient uses, the 
greater the chance of drug interference. Other studies 
confirm this result, for example, in one study showing a 
linear relationship between the number of drugs and drug 
interactions. Another study also found that 15 percent of 
people taking multiple medications had significant and 
dangerous drug interactions17-19 Some patients take other 
medicines arbitrarily, regardless of the drug interference 
problem, with the current prescription medication, 
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adverse drug reactions to ensure drug interference.
It recommended that physicians pay more attention to 
other medications used by the patient and consider their 
drug interactions.  Also, prescribe as little as possible of the 
drug and the drug with the least number of interactions.
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